About Us
We are developing an IV-administered cell therapy engineered to home to sites of injury in the brain.
TET Therapeutics is a pre-seed biotech startup developing an IV-deliverable cell therapy for brain injury repair. Our approach is based on fetomaternal microchimerism: a validated biological phenomenon in which CCR2-high myeloid progenitors cross the blood-brain barrier and home to sites of maternal brain injury. We are engineering this mechanism into a scalable therapeutic platform.
